Ho In Geol, Kim Jae Keun, Hwang Ho Kyoung, Kim Jae Young, Park Joon Seong, Yoon Dong Sup
Pancreatobiliary Cancer Clinic, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Korean J Hepatobiliary Pancreat Surg. 2014 Aug;18(3):90-3. doi: 10.14701/kjhbps.2014.18.3.90. Epub 2014 Aug 31.
BACKGROUNDS/AIMS: Few reports have validated the clinical postoperative pancreatic fistula (PF) after distal pancreatectomy. The study intended to validate the predictability for clinical PF of drain amylase and lipase and to find out more appropriate postoperative day (POD) for diagnostic criterion of PF.
A total of 154 patients underwent distal pancreatectomy. We used the clinical database registry system of the Gangnam Severance Hospital and Severance Hospital, Yonsei University Health System for these analyses. The receiver operating characteristic curve of the drain amylase or lipase concentration on each day was used to predict clinical PF (International Study Group on Pancreatic Fistula [ISGPF] grade B or C) and areas under the curves (AUC) were compared.
Amylase and lipase AUC values poorly predicted clinical PF before POD 3 and, gradually increased until POD 5 and became well correlated with clinical PF (ISGPF grade B or C). In contrast, the prediction of clinical PF using drain lipase did not differ from that using drain amylase. The drain amylase concentration on POD 6 was most precisely correlated with clinical PF.
Clinical PF prediction was validated by using drain amylase and lipase concentrations, in which drain amylase assessment at POD 6 appeared to be an appropriate diagnostic criterion of PF after distal pancreatectomy. We suggest some modification of ISGPF definition, especially for distal pancreatectomy.
背景/目的:关于胰体尾切除术后临床胰瘘(PF)的验证报告较少。本研究旨在验证引流液淀粉酶和脂肪酶对临床PF的预测能力,并找出更合适的PF诊断标准术后天数(POD)。
共有154例患者接受了胰体尾切除术。我们使用延世大学医疗系统江南Severance医院和Severance医院的临床数据库登记系统进行这些分析。利用每天引流液淀粉酶或脂肪酶浓度的受试者工作特征曲线来预测临床PF(国际胰瘘研究组[ISGPF] B级或C级),并比较曲线下面积(AUC)。
淀粉酶和脂肪酶的AUC值在术后第3天前对临床PF预测效果不佳,至术后第5天逐渐升高,并与临床PF(ISGPF B级或C级)呈现良好的相关性。相比之下,使用引流液脂肪酶预测临床PF与使用引流液淀粉酶并无差异。术后第6天的引流液淀粉酶浓度与临床PF的相关性最为精确。
通过使用引流液淀粉酶和脂肪酶浓度验证了临床PF预测能力,其中术后第6天的引流液淀粉酶评估似乎是胰体尾切除术后PF的合适诊断标准。我们建议对ISGPF定义进行一些修改,特别是针对胰体尾切除术。